Stockreport

Genmab Announces Financial Results for the First Quarter of 2024 [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF The U.S. Food and Drug Administration (U.S. FDA) granted Priority Review for the supplemental Biologics License Application (sBLA) for EPKINLY ® (epcoritamab-bysp) for [Read more]